Handelsbanken Fonder’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,600
| Closed | -$1.3M | – | 1651 |
|
|
2022
Q3 | $1.3M | Sell |
8,600
-56,000
| -87% | -$8.47M | 0.01% | 588 |
|
|
2022
Q2 | $9.41M | Sell |
64,600
-214,000
| -77% | -$31.2M | 0.06% | 302 |
|
|
2022
Q1 | $33M | Sell |
278,600
-8,500
| -3% | -$1.01M | 0.18% | 125 |
|
|
2021
Q4 | $39.6M | Buy |
287,100
+9,500
| +3% | +$1.31M | 0.19% | 124 |
|
|
2021
Q3 | $38.6M | Sell |
277,600
-15,000
| -5% | -$2.08M | 0.2% | 113 |
|
|
2021
Q2 | $28.4M | Buy |
292,600
+25,000
| +9% | +$2.43M | 0.15% | 155 |
|
|
2021
Q1 | $18.3M | Buy |
267,600
+35,000
| +15% | +$2.39M | 0.1% | 196 |
|
|
2020
Q4 | $19.9M | Sell |
232,600
-36,900
| -14% | -$3.16M | 0.12% | 173 |
|
|
2020
Q3 | $17.5M | Buy |
269,500
+25,200
| +10% | +$1.64M | 0.13% | 167 |
|
|
2020
Q2 | $17.9M | Sell |
244,300
-2,700
| -1% | -$197K | 0.15% | 140 |
|
|
2020
Q1 | $8.41M | Sell |
247,000
-10,000
| -4% | -$340K | 0.18% | 125 |
|
|
2019
Q4 | $14M | Buy |
257,000
+25,000
| +11% | +$1.36M | 0.24% | 110 |
|
|
2019
Q3 | $9.68M | Buy |
232,000
+80,000
| +53% | +$3.34M | 0.2% | 122 |
|
|
2019
Q2 | $6.66M | Buy |
+152,000
| New | +$6.66M | 0.12% | 153 |
|